Created in 1990 (Belgium), SAPROXAL own 2466 sister brands and 17477 competing brands. SAPROXAL is a brand of JOHNSON & JOHNSON, listed on the stock exchange of New York. SAPROXAL is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(SAPROXAL)
over 5 years*
USD 147.49